Sun Pharmaceutical
SUNPHARMA.NS
#403
Rank
โ‚น4.318 T
Marketcap
โ‚น1,800
Share price
-0.47%
Change (1 day)
46.25%
Change (1 year)

Revenue for Sun Pharmaceutical (SUNPHARMA.NS)

Revenue in 2024 (TTM): โ‚น497.58 Billion

According to Sun Pharmaceutical 's latest financial reports the company's current revenue (TTM ) is โ‚น505.13 Billion. In 2023 the company made a revenue of โ‚น466.70 Billion an increase over the revenue in the year 2022 that were of โ‚น419.39 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sun Pharmaceutical from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น497.58 B6.62%
2023 โ‚น466.70 B11.28%
2022 โ‚น419.39 B11.92%
2021 โ‚น374.71 B14.08%
2020 โ‚น328.47 B4.97%
2019 โ‚น312.91 B10.36%
2018 โ‚น283.53 B8.3%
2017 โ‚น261.80 B-15.15%
2016 โ‚น308.55 B16.12%
2015 โ‚น265.72 B5.35%
2014 โ‚น252.21 B67.72%
2013 โ‚น150.37 B43.31%
2012 โ‚น104.93 B